[1]
2020. Case Report on Liposomal Doxorubicin Induced Anaphylaxis. World Journal of Current Medical and Pharmaceutical Research. 2, 2 (May 2020), 157–158. DOI:https://doi.org/10.37022/WJCMPR.2020.2213.